Church & Dwight Co., Inc.

CHD Details

Church & Dwight Co., Inc. (NYSE: CHD) is engaged in developing, manufacturing, and distributing a wide range of consumer household and personal care products and specialty goods for animal and food production, chemicals, and cleaners. CHD markets its consumer products via 14 different power brands. As of January 11, 2022, the company's market capitalization stood at USD 25.10 billion.

Latest News:

• Declaration of Dividend: On October 27, 2021, CHD declared a quarterly dividend of USD 0.2525 per common share, paid on December 01, 2021, to shareholders of record on November 15, 2021.
• Strategic Investment: On December 27, 2021, CHD acquired TheraBreath, a leading alcohol-free mouthwash brand in the US, for the cash consideration of USD 580 million. TheraBreath will be positioned as the CHD 14^th power brand and represents a significant addition to the existing oral care portfolio.

Q3FY21 Results:

• Growth in Revenue: The company reported YoY growth of 5.67% in revenues to USD 1.31 billion in Q3FY21 (ended September 30, 2021) from USD 1.24 billion in Q3FY20, driven by increased demand for its products.
• Improvement in Profitability: CHD reported growth in net income to USD 230.4 million in Q3FY21 vs. USD 216.2 million in Q3FY20.
• Cash and Debt Position: As of September 30, 2021, the company had cash and cash equivalents of USD 180.0 million and total debt of USD 1.79 billion.

Key Risks:

• Customer Concentration Risk: In FY20, Walmart was the company's largest customer, accounting for nearly 23% of net sales. Furthermore, the top three customers accounted for 36% of CHD's revenue during the fiscal year. As a result, losing any of these critical customers could harm the company's top-line.
• Competition Risk: CHD competes directly with established competitors like The Proctor & Gamble Company, Colgate-Palmolive Company, Henkel, Reckitt Benckiser Group plc, Johnson & Johnson, and others in the consumer products business. As a result, any unfavorable shift in demand for CHD's products could result in pricing pressure and market share loss, negatively impacting the company's results of operations.

Outlook:

• FY21 Estimates: As of Q3FY21, CHD expects organic sales growth of ~4% and net sales growth of ~5.5% in FY21. It also anticipates Adjusted EPS growth of 6% and generating cash flow from the operation of ~USD 950 million.

Valuation Methodology: EV/Sales Multiple Based Relative Valuation

(Analysis by Kalkine Group)

• % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

CHD Daily Technical Chart (Source: REFINITIV)

Stock Recommendation:

CHD's stock price has increased 23.33% in the past three months and is currently trading close to the higher-band of its 52-week range of USD 77.62 to USD 104.39. The stock is currently trading above its 50 and 200 DMA levels, and its RSI Index is at 61.86. We have valued the stock using the EV/Sales-based relative valuation methodology and arrived at a target price of USD 90.48.

Considering the uptick in the stock price, technical indicators, and current valuation, we believe the decent business fundamentals are adequately reflected at current trading levels. Hence, we recommend a "Sell" rating on the stock at the closing price of USD 101.82, down 0.95%, as of January 11, 2022.

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.